Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Phase 2 Trial

Recent news which mentions Phase 2 Trial

< Previous 1 2 3 4 5 6 7 8 9 Next >
Clene Nanomedicine Presents Updated Data From Mid-Stage Amyotrophic Lateral Sclerosis Trials
Tickers CLNN
Tags Market News Benzinga CLNN
From Benzinga
BridgeBio Pharma Posts Updated Data From Muscular Dystrophy Trial, Plots Path To Market
Tickers BBIO
Tags BBIO News Small Cap
From Benzinga
Scholar Rock To Highlight Apitegromab Data From Ambulatory Cohort In Muscular Dystrophy
Tickers SRRK
Tags Market News SRRK Spinal Muscular Atrophy
From Benzinga
Why Sanofi Shares Are Trading Lower Today
Tickers SNY
Tags General Briefs Movers
From Benzinga
Moderna Starts Dosing In Mid-Stage Omicron-Specific Bivalent Booster Candidate
Tickers MRNA
Tags Biotech MRNA News
From Benzinga
FDA Gives Green Signal To Inventiva's Mid-Stage Lanifibranor Study In NASH Patients
Tickers IVA
Tags Benzinga Market News Phase 2 Trial
From Benzinga
Alkermes' Nemvaleukin Shows Encouraging Anti-Tumor Activity In Pretreated Kidney Cancer
Tickers ALKS
Tags Biotech Trading Ideas Benzinga
From Benzinga
Amgen Posts Latest Batch of Lumakras Data In Pancreatic Cancer
Tickers AMGN
Tags Biotech News Phase 1 Trial
From Benzinga
ImmunityBio's Ankitva Shows 100% Survival At Two Years In Bladder Cancer Setting
Tickers ENDP IBRX MRK
Tags MRK Penny Stocks Health Care
From Benzinga
BioXcel BXCL701 Combo Therapy Shows Encouraging Response Rates In Prostate Cancer
Tickers BTAI MRK
Tags Biotech BTAI MRK
From Benzinga
Opthea Shares OPT-302 data In Patients With Subtype Of Age-Related Macular Degeneration
Tickers OPT
Tags OPT Health Care Briefs
From Benzinga
RegenXBio Posts Updated Data From Hunter Syndrome Gene Therapy Trial
Tickers RGNX
Tags Phase 2 Trial gene therapy Benzinga
From Benzinga
4D Molecular Shares Updated Data From Fabry Disease Trial
Tickers FDMT
Tags FDMT Health Care Phase 2 Trial
From Benzinga
After Fabry Trial Setback, Avrobio Hopes Rebound With Lysosomal Storage Disorder Data
Tickers AVRO
Tags Market News General AVRO
From Benzinga
Why Are NLS Pharmaceutics Shares Trading Higher During Premarket Monday?
Tickers NLSP
Tags NLSP Phase 2 Trial Trading Ideas
From Benzinga
Valneva - Pfizer Choose Three-Dose Schedule For Lyme Vaccine Candidate Moving Forward
Tickers PFE VALN
Tags News Small Cap Market News
From Benzinga
Altimmune's Mid-Stage Pemvidutide Study Cleared By FDA For Obesity
Tickers ALT
Tags Phase 2 Trial Trading Ideas Benzinga
From Benzinga
Kaleido Halts Upcoming Phase 2 COPD Trial, Piper Sandler Cuts Price Target
Tickers JNJ KLDO
Tags Biotech Analyst Ratings JNJ
From Benzinga
Taysha Gene Plans Protocol Amendment After Patient Death In Gene Therapy Trial
Tickers TSHA
Tags Health Care TSHA Trading Ideas
From Benzinga
4D Pharma's Asthma Candidate Shows Positive Trends In Multiple Secondary Endpoints Of Efficacy
Tickers LBPS
Tags Phase 1 Trial News Market News
From Benzinga
Why Are Tyme Technologies Shares Staring At 52-Week Low
Tickers TYME
Tags Movers Market News General
From Benzinga
Two Organizations To Support Wave Life Sciences' FTD, ALS Program
Tickers WVE
Tags Biotech WVE News
From Benzinga
Imara To Start Testing Tovinontrine In Heart Failure Patients
Tickers IMRA
Tags Market News Movers Briefs
From Benzinga
FDA Holds Mustang Bio's Gene Therapy IND For Compromised Immune System Disorder
Tickers FBIO MBIO
Tags General Briefs Market News
From Benzinga
89bio's NASH Candidate Shows Improvement In Disease Severity, Cardiovascular Health
Tickers ETNB
Tags Phase 1 Trial News Biotech
From Benzinga
Tango Therapeutics' TNG908 IND For Cancer Study Gets Green Signal By FDA
Tickers TNGX
Tags Briefs General Market News
From Benzinga
On Positive Virology Data, SAB Biotherapeutics' COVID-19 Drug To Move To Phase 3 In NIH ACTIV-2 Trial
Tickers SABS
Tags Market News COVID/19 Coronavirus Benzinga
From Benzinga
MediWound's EscharEx Mid-Stage Trial Meets Primary Goal In Venous Leg Ulcers
Tickers MDWD
Tags News Penny Stocks Health Care
From Benzinga
Mirati Therapeutics Posts 41% Objective Response Rate In Pretreated GI Cancer Patients
Tickers MRTX
Tags Biotech News Benzinga
From Benzinga
Provention Bio Starts Mid-Stage Lupus Trial; Data Expected In 2024
Tickers PRVB
Tags PRVB Benzinga Phase 2 Trial
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.